Caitlin Schneider

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Topics

Magnetic Resonance

Top Venues

Hepatology communications

International journal of hepatology

This page only lists publications with an associated author ORCID identifier.

Publications

Stephen Caldwell, Alnoor Ramji, Tarek Hassanein, Eric M Yoshida, Emily Pang, Caitlin Schneider, Michael P Curry, Nezam H Afdhal
Velacur ACE outperforms FibroScan CAP for diagnosis of MASLD. Hepatology communications 8 (4) (2024)
Stephen Caldwell, Alnoor Ramji, Tarek Hassanein, Eric M Yoshida, Emily Pang, Caitlin Schneider, Michael P Curry, Nezam H Afdhal
Velacur ACE outperforms FibroScan CAP for diagnosis of MASLD. Hepatology communications 8 (4) (2024)
Stephen Caldwell, Alnoor Ramji, Tarek Hassanein, Eric M Yoshida, Emily Pang, Caitlin Schneider, Michael P Curry, Nezam H Afdhal
Velacur ACE outperforms FibroScan CAP for diagnosis of MASLD. Hepatology communications 8 (4) (2024)
Michael P Curry, Edward Tam, Caitlin Schneider, Noha Abdelgelil, Tarek Hassanein, Nezam H Afdhal
The Use of Noninvasive Velacur® for Discriminating between Volunteers and Patients with Chronic Liver Disease: A Feasibility Study. International journal of hepatology 2024 (2024)
Stephen Caldwell, Alnoor Ramji, Tarek Hassanein, Eric M Yoshida, Emily Pang, Caitlin Schneider, Michael P Curry, Nezam H Afdhal
Velacur ACE outperforms FibroScan CAP for diagnosis of MASLD. Hepatology communications 8 (4) (2024)
Michael P Curry, Edward Tam, Caitlin Schneider, Noha Abdelgelil, Tarek Hassanein, Nezam H Afdhal
The Use of Noninvasive Velacur® for Discriminating between Volunteers and Patients with Chronic Liver Disease: A Feasibility Study. International journal of hepatology 2024 (2024)
Stephen Caldwell, Alnoor Ramji, Tarek Hassanein, Eric M Yoshida, Emily Pang, Caitlin Schneider, Michael P Curry, Nezam H Afdhal
Velacur ACE outperforms FibroScan CAP for diagnosis of MASLD. Hepatology communications 8 (4) (2024)